Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Neoplasms of the CNS

Free Subscription Articles published in J Nucl Med Retrieve available abstracts of 40 articles: HTML format Text format

Single Articles

March 2018
1. JANNETTI SA, Carlucci G, Carney B, Kossatz S, et al
   PARP1-Targeted Radiotherapy in Mouse Models of Glioblastoma.
   J Nucl Med. 2018 Mar 23. pii: jnumed.117.205054. doi: 10.2967/jnumed.117.205054.
   PubMed     Text format     Abstract available
   
   
   December 2017
2. OYEN WJG, Jones C
   ImmunoPET in pontine glioma : more than meets the eye ?
   J Nucl Med. 2017 Dec 7. pii: jnumed.117.200527. doi: 10.2967/jnumed.117.200527.
   PubMed     Text format    
   
   
   November 2017
3. PAPP L, Poetsch N, Grahovac M, Schmidbauer V, et al
   Glioma survival prediction with the combined analysis of in vivo 11C-MET-PET, ex vivo and patient features by supervised machine learning.
   J Nucl Med. 2017 Nov 24. pii: jnumed.117.202267. doi: 10.2967/jnumed.117.202267.
   PubMed     Text format     Abstract available
   
   
   August 2017
4. MAULER J, Maudsley AA, Langen KJ, Nikoubashman O, et al
   Spatial Relationship of Glioma Volume Derived from FET PET and Volumetric MRSI: a hybrid PET-MRI study.
   J Nucl Med. 2017 Aug 28. pii: jnumed.117.196709. doi: 10.2967/jnumed.117.196709.
   PubMed     Text format     Abstract available
   
   
   
5. VELDHUIJZEN VAN ZANTEN SEM, Sewing ACP, van Lingen A, Hoekstra OS, et al
   Multiregional tumor drug-uptake imaging by PET and microvascular morphology in end-stage diffuse intrinsic pontine glioma.
   J Nucl Med. 2017 Aug 17. pii: jnumed.117.197897. doi: 10.2967/jnumed.117.197897.
   PubMed     Text format     Abstract available
   
   
   
6. RICHARD MA, Fouquet JP, Lebel R, Lepage M, et al
   Determination of an Optimal Pharmacokinetic Model of 18F-FET for Quantitative Applications in Rat Brain Tumors.
   J Nucl Med. 2017;58:1278-1284.
   PubMed     Text format     Abstract available
   
   
   June 2017
7. FERREIRA DA PONTE K, Berro DH, Collet S, Constans JM, et al
   In vivo relationship between hypoxia and angiogenesis in human glioblastoma: a multimodal imaging study.
   J Nucl Med. 2017 Jun 8. pii: jnumed.116.188557. doi: 10.2967/jnumed.116.188557.
   PubMed     Text format     Abstract available
   
   
   May 2017
8. SEGTNAN EA, Grupe P, Jarden JO, Gerke O, et al
   Prognostic Implications of Total Hemispheric Glucose Metabolism Ratio in Cerebrocerebellar Diaschisis.
   J Nucl Med. 2017;58:768-773.
   PubMed     Text format     Abstract available
   
   
   April 2017
9. KUNZ WG, Jungblut LM, Kazmierczak PM, Vettermann FJ, et al
   Improved Detection of Transosseous Meningiomas Using 68Ga-DOTATATE PET-CT Compared to Contrast-Enhanced MRI.
   J Nucl Med. 2017 Apr 27. pii: jnumed.117.191932. doi: 10.2967/jnumed.117.191932.
   PubMed     Text format     Abstract available
   
   
   
10. GERSTNER E
    MRI and PET: noninvasive tools to probe diffuse intrinsic pontine glioma biology.
    J Nucl Med. 2017 Apr 6. pii: jnumed.117.192526. doi: 10.2967/jnumed.117.192526.
    PubMed     Text format    
    
    
    March 2017
11. ZUKOTYNSKI K, Vajapeyam S, Fahey FH, Kocak M, et al
    Correlation of 18F-FDG PET and MR Apparent Diffusion Coefficient (ADC) Histogram Metrics with Survival in Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium.
    J Nucl Med. 2017 Mar 30. pii: jnumed.116.185389. doi: 10.2967/jnumed.116.185389.
    PubMed     Text format     Abstract available
    
    
    
12. RAUSCH I, Rischka L, Ladefoged CN, Furtner J, et al
    PET/MRI for oncological brain imaging: A comparison of standard MR-based attenuation corrections with a novel, model-based approach for the Siemens mMR PET/MR system.
    J Nucl Med. 2017 Mar 2. pii: jnumed.116.186148. doi: 10.2967/jnumed.116.186148.
    PubMed     Text format     Abstract available
    
    
    February 2017
13. STEGMAYR C, Oliveira D, Niemietz N, Willuweit A, et al
    Influence of bevacizumab on blood-brain barrier permeability and O-(2-18F-fluoroethyl)-L-tyrosine uptake in rat gliomas.
    J Nucl Med. 2017 Feb 2. pii: jnumed.116.187047. doi: 10.2967/jnumed.116.187047.
    PubMed     Text format     Abstract available
    
    
    November 2016
14. WONG FC
    Brain Tumor Imaging.
    J Nucl Med. 2016 Nov 17. pii: jnumed.116.186957.
    PubMed     Text format    
    
    
    October 2016
15. MICHELHAUGH SK, Muzik O, Guastella AR, Klinger NV, et al
    Assessment of tryptophan uptake and kinetics using 1-(2-[18F]fluoroethyl)-L-tryptophan and alpha-[11C]-methyl-L-tryptophan PET imaging in mice implanted with patient-derived brain tumor xenografts.
    J Nucl Med. 2016 Oct 20. pii: jnumed.116.179994.
    PubMed     Text format     Abstract available
    
    
    
16. JANSEN M, Veldhuijzen van Zanten SE, Van Vuurden DG, Huisman M, et al
    Molecular Drug Imaging: 89Zr-bevacizumab PET in Children with Diffuse Intrinsic Pontine Glioma.
    J Nucl Med. 2016 Oct 20. pii: jnumed.116.180216.
    PubMed     Text format     Abstract available
    
    
    
17. UNTERRAINER M, Galldiks N, Suchorska B, Kowalew LC, et al
    18F-FET PET uptake characteristics in patients with newly diagnosed and untreated brain metastasis.
    J Nucl Med. 2016 Oct 6. pii: jnumed.116.180075.
    PubMed     Text format     Abstract available
    
    
    September 2016
18. LODGE MA, Holdhoff M, Leal JP, Bag AK, et al
    Repeatability of 18F-FLT PET in a Multi-Center Study of Patients with High Grade Glioma.
    J Nucl Med. 2016 Sep 29. pii: jnumed.116.178434.
    PubMed     Text format     Abstract available
    
    
    July 2016
19. HUTTERER M, Ebner Y, Riemenschneider MJ, Willuweit A, et al
    Epileptic activity increases cerebral amino acid transport assessed by [18F]-fluoroethyl-L-tyrosine amino acid PET - a potential brain tumor mimic.
    J Nucl Med. 2016 Jul 28. pii: jnumed.116.176610.
    PubMed     Text format     Abstract available
    
    
    June 2016
20. RADOJEWSKI P, Dumont R, Manrincek N, Brunner P, et al
    Reply: The future of radiopeptide therapy in patients with progressive meningioma.
    J Nucl Med. 2016 Jun 30. pii: jnumed.116.178145.
    PubMed     Text format    
    
    
    
21. BEHLING K, DiGialleonardo V, Maguire WF, Heeb LE, et al
    Remodelling the vascular microenvironment of glioblastoma with alpha-particles.
    J Nucl Med. 2016 Jun 3. pii: jnumed.116.173559.
    PubMed     Text format     Abstract available
    
    
    April 2016
22. BEHLING K, Maguire WF, Puebla JC, Sprinkle SR, et al
    Vascular targeted radioimmunotherapy for the treatment of glioblastoma.
    J Nucl Med. 2016 Apr 28. pii: jnumed.115.171371.
    PubMed     Text format     Abstract available
    
    
    
23. HUAILEI J, Bansal A, Pandey M, Peng KW, et al
    Synthesis of 18F-Tetrafluoroborate (18F-TFB) via Radiofluorination of Boron Trifluoride and Evaluation in a Murine C6-Glioma Tumor Model.
    J Nucl Med. 2016 Apr 21. pii: jnumed.115.170894.
    PubMed     Text format     Abstract available
    
    
    
24. KLETTING P, Kull T, Maass C, Malik N, et al
    Optimized Peptide Amount and Activity for (9)(0)Y-Labeled DOTATATE Therapy.
    J Nucl Med. 2016;57:503-8.
    PubMed     Text format     Abstract available
    
    
    March 2016
25. UNTERRAINER M, Schweisthal F, Suchorska B, Wenter V, et al
    Serial 18F-FET PET imaging of primarily 18F-FET-negative glioma - does it make sense?
    J Nucl Med. 2016 Mar 31. pii: jnumed.115.171033.
    PubMed     Text format     Abstract available
    
    
    
26. SEKINE T, Burgos N, Warnock G, Huellner MW, et al
    Multi atlas-based attenuation correction for brain FDG-PET imaging using a TOF-PET/MR scanner- comparison with clinical single atlas- and CT-based attenuation correction.
    J Nucl Med. 2016 Mar 24. pii: jnumed.115.169045.
    PubMed     Text format     Abstract available
    
    
    February 2016
27. SINDONI A
    SOMATOSTATIN RECEPTOR-TARGETED RADIOPEPTIDE THERAPY IN PATIENTS WITH PROGRESSIVE UNRESECTABLE MENINGIOMA.
    J Nucl Med. 2016 Feb 25. pii: jnumed.116.172312.
    PubMed     Text format    
    
    
    
28. MODAK S, Zanzonico P, Carrasquillo JA, Kushner BH, et al
    Arsenic Trioxide as a Radiation Sensitizer for 131I-Metaiodobenzylguanidine Therapy: Results of a Phase II Study.
    J Nucl Med. 2016;57:231-7.
    PubMed     Text format     Abstract available
    
    
    November 2015
29. NIU G, Chen X
    RGD PET: From Lesion Detection to Therapy Response Monitoring.
    J Nucl Med. 2015 Nov 25. pii: jnumed.115.168278.
    PubMed     Text format    
    
    
    
30. CHENG SH, Yu D, Tsai HM, Morshed RA, et al
    Dynamic In Vivo SPECT Imaging of Neural Stem Cells Functionalized with Radiolabeled Nanoparticles for Tracking of Glioblastoma.
    J Nucl Med. 2015 Nov 12. pii: jnumed.115.163006.
    PubMed     Text format     Abstract available
    
    
    October 2015
31. ZHANG H, Liu N, Gao S, Hu X, et al
    Can a Novel 18F-ALF-NOTA-PRGD2 PET/CT Predict the Treatment Sensitivity of Concurrent Chemoradiotherapy in Patients with Newly Diagnosed Glioblastoma?
    J Nucl Med. 2015 Oct 29. pii: jnumed.115.165514.
    PubMed     Text format     Abstract available
    
    
    
32. ZHANG J, Li D, Lang L, Zhu Z, et al
    68Ga-NOTA-Aca-BBN(7-14) PET/CT in Healthy Volunteers and Glioma Patients.
    J Nucl Med. 2015 Oct 8. pii: jnumed.115.165316.
    PubMed     Text format     Abstract available
    
    
    
33. PERSSON M, Nedergaard M, Brandt-Larsen M, Skovgaard D, et al
    uPAR is a Promising New Imaging Biomarker in Glioblastoma.
    J Nucl Med. 2015 Oct 1. pii: jnumed.115.161703.
    PubMed     Text format     Abstract available
    
    
    
34. HIRATA K, Tamaki N
    uPAR as a Glioma Imaging Target.
    J Nucl Med. 2015 Oct 1. pii: jnumed.115.166231.
    PubMed     Text format    
    
    
    August 2015
35. GERSTER-GILLIERON K, Forrer F, Maecke H, Mueller-Brand J, et al
    90Y-DOTATOC as Therapeutic Option for Complex Recurrent or Progressive Meningiomas.
    J Nucl Med. 2015 Aug 20. pii: jnumed.115.155853.
    PubMed     Text format     Abstract available
    
    
    
36. FINK J, Muzi M, Peck M, Krohn KA, et al
    Multi-modality Brain Tumor Imaging - MRI, PET, and PET/MRI.
    J Nucl Med. 2015 Aug 20. pii: jnumed.113.131516.
    PubMed     Text format     Abstract available
    
    
    
37. MUZI M, Peterson LM, O'Sullivan JN, Fink JR, et al
    18F-Fluoromisonidazole Quantification of Hypoxia in Human Cancer Patients Using Image-Derived Blood Surrogate Tissue Reference Regions.
    J Nucl Med. 2015;56:1223-8.
    PubMed     Text format     Abstract available
    
    
    July 2015
38. HALLE B, Thisgaard H, Hvidsten S, Dam JH, et al
    Estimation of Tumor Volumes by [11C]MeAIB and [18F]FDG PET in an Orthotopic Glioblastoma Rat Model.
    J Nucl Med. 2015 Jul 30. pii: jnumed.115.162511.
    PubMed     Text format     Abstract available
    
    
    
39. JENSEN P, Feng L, Law I, Svarer C, et al
    TSPO imaging in glioblastoma multiforme: A direct comparison between 123ICLINDE-SPECT, 18F-FET PET and gadolinium-enhanced MRI.
    J Nucl Med. 2015 Jul 16. pii: jnumed.115.158998.
    PubMed     Text format     Abstract available
    
    
    
40. DEN HOLLANDER MW, Bensch F, Glaudemans AW, Oude Munnink TH, et al
    TGF-beta antibody uptake in recurrent high grade glioma imaged with 89Zr-fresolimumab PET.
    J Nucl Med. 2015 Jul 1. pii: jnumed.115.154401.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: